{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:24:50Z","timestamp":1761207890163,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14694-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:20:33Z","timestamp":1761207633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cyclic cytokines mediated the effect of immune cells on meningioma: a two-step, mediation mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingsheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"Suppl 5","key":"14694_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 2019;21(Suppl 5):v1\u2013100.","journal-title":"Neuro Oncol"},{"key":"14694_CR2","doi-asserted-by":"publisher","first-page":"101562","DOI":"10.1016\/j.canep.2019.07.001","volume":"62","author":"B Holleczek","year":"2019","unstructured":"Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J, et al. Incidence, mortality and outcome of meningiomas: a population-based study from Germany. Cancer Epidemiol. 2019;62:101562.","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"14694_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"4","key":"14694_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1158\/1055-9965.EPI-04-0366","volume":"14","author":"S Sadetzki","year":"2005","unstructured":"Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B, et al. Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev. 2005;14(4):969\u201376.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"14694_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hoc.2021.08.012","volume":"36","author":"SS Francis","year":"2022","unstructured":"Francis SS, Ostrom QT, Cote DJ, Smith TR, Claus E, Barnholtz-Sloan JS. The epidemiology of central nervous system tumors. Hematol Oncol Clin North Am. 2022;36(1):23\u201342.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"14694_CR6","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/ijc.25858","volume":"129","author":"JL Wiemels","year":"2011","unstructured":"Wiemels JL, Wrensch M, Sison JD, Zhou M, Bondy M, Calvocoressi L, et al. Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer. 2011;129(8):1932\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"14694_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ijc.10320","volume":"99","author":"AV Brenner","year":"2002","unstructured":"Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer. 2002;99(2):252\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"14694_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cdp.2005.07.002","volume":"29","author":"B Schneider","year":"2005","unstructured":"Schneider B, P\u00fclhorn H, R\u00f6hrig B, Rainov NG. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev. 2005;29(5):440\u20137.","journal-title":"Cancer Detect Prev"},{"issue":"10","key":"14694_CR9","first-page":"6973","volume":"7","author":"Y Ding","year":"2014","unstructured":"Ding Y, Qiu L, Xu Q, Song L, Yang S, Yang T. Relationships between tumor microenvironment and clinicopathological parameters in meningioma. Int J Clin Exp Pathol. 2014;7(10):6973\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"14694_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-031-29750-2_14","volume":"1416","author":"JZ Wang","year":"2023","unstructured":"Wang JZ, Nassiri F, Bi L, Zadeh G. Immune Profiling of Meningiomas. Adv Exp Med Biol. 2023;1416:189\u201398.","journal-title":"Adv Exp Med Biol"},{"key":"14694_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fneur.2020.00945","volume":"11","author":"T Garzon-Muvdi","year":"2020","unstructured":"Garzon-Muvdi T, Bailey DD, Pernik MN, Pan E. Basis for immunotherapy for treatment of meningiomas. Front Neurol. 2020;11:945.","journal-title":"Front Neurol"},{"issue":"13","key":"14694_CR12","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1158\/0008-5472.CAN-11-4094","volume":"72","author":"SP Kerkar","year":"2012","unstructured":"Kerkar SP, Restifo NP. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 2012;72(13):3125\u201330.","journal-title":"Cancer Res"},{"issue":"3","key":"14694_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jcp.41.3.314","volume":"41","author":"ML Rossi","year":"1988","unstructured":"Rossi ML, Cruz Sanchez F, Hughes JT, Esiri MM, Coakham HB. Immunocytochemical study of the cellular immune response in meningiomas. J Clin Pathol. 1988;41(3):314\u20139.","journal-title":"J Clin Pathol"},{"issue":"5","key":"14694_CR14","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.3390\/ijms13056424","volume":"13","author":"H Tang","year":"2012","unstructured":"Tang H, Gong Y, Mao Y, Xie Q, Zheng M, Wang D, et al. CD133-positive cells might be responsible for efficient proliferation of human meningioma cells. Int J Mol Sci. 2012;13(5):6424\u201339.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"14694_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/neuonc\/not110","volume":"15","author":"L Fang","year":"2013","unstructured":"Fang L, Lowther DE, Meizlish ML, Anderson RC, Bruce JN, Devine L, et al. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells. Neuro Oncol. 2013;15(11):1479\u201390.","journal-title":"Neuro Oncol"},{"issue":"4","key":"14694_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/neuros\/nyz438","volume":"87","author":"J Engelhardt","year":"2020","unstructured":"Engelhardt J, Nunes ML, Pouchieu C, Ferri\u00e8re A, San-Galli F, Gimbert E, et al. Increased incidence of intracranial meningiomas in patients with acromegaly. Neurosurgery. 2020;87(4):639\u201346.","journal-title":"Neurosurgery"},{"key":"14694_CR17","doi-asserted-by":"publisher","first-page":"101946","DOI":"10.1016\/j.canep.2021.101946","volume":"73","author":"D Shi","year":"2021","unstructured":"Shi D, Ao L, Yu H, Li J, Xia Y, Wu X, et al. Diabetes increases the risk of meningioma: a systematic review and meta-analysis of observational studies. Cancer Epidemiol. 2021;73:101946.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"14694_CR18","doi-asserted-by":"publisher","first-page":"e70287","DOI":"10.1111\/cns.70287","volume":"31","author":"H Tang","year":"2025","unstructured":"Tang H, Xu F, Sun D, Hua L, Xiong J, Xu M, et al. Cas9 mouse model of skull base meningioma driven by combinational gene inactivation in meningeal cells. CNS Neurosci Ther. 2025;31(2):e70287.","journal-title":"CNS Neurosci Ther"},{"issue":"19","key":"14694_CR19","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925\u20136.","journal-title":"JAMA"},{"issue":"10","key":"14694_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet"},{"issue":"9","key":"14694_CR21","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman \u00c5K, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540\u201351.","journal-title":"Nat Immunol"},{"issue":"7944","key":"14694_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. Finngen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"1","key":"14694_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"14694_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"7","key":"14694_CR25","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.7150\/jca.92699","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Yu X, Wu X, Chai K, Wang S. Causal relationships between gut microbiota, immune cell, and non-small cell lung cancer: a two-step, two-sample Mendelian randomization study. J Cancer. 2024;15(7):1890\u20137.","journal-title":"J Cancer"},{"key":"14694_CR26","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"issue":"11","key":"14694_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880\u2013906.","journal-title":"Stat Med"},{"issue":"7","key":"14694_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","volume":"30","author":"HE Lynch","year":"2009","unstructured":"Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol. 2009;30(7):366\u201373.","journal-title":"Trends Immunol"},{"key":"14694_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.exger.2014.01.003","volume":"54","author":"V Appay","year":"2014","unstructured":"Appay V, Sauce D. Naive T cells: the crux of cellular immune aging? Exp Gerontol. 2014;54:90\u20133.","journal-title":"Exp Gerontol"},{"issue":"4","key":"14694_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12(4):265\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"14694_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/nm1325","volume":"11","author":"M Kortylewski","year":"2005","unstructured":"Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med. 2005;11(12):1314\u201321.","journal-title":"Nat Med"},{"issue":"7","key":"14694_CR32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1084\/jem.20050463","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med. 2005;202(7):919\u201329.","journal-title":"J Exp Med"},{"issue":"5","key":"14694_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1084\/jem.20061120","volume":"204","author":"C Aspord","year":"2007","unstructured":"Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, et al. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med. 2007;204(5):1037\u201347.","journal-title":"J Exp Med"},{"key":"14694_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"14694_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"14694_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tips.2013.02.004","volume":"34","author":"A Dufour","year":"2013","unstructured":"Dufour A, Overall CM. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci. 2013;34(4):233\u201342.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"14694_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cup.13603","volume":"47","author":"G Zamolo","year":"2020","unstructured":"Zamolo G, Grahovac M, \u017dauhar G, Vu\u010dini\u0107 D, Kova\u010d L, Brajeni\u0107 N, et al. Matrix metalloproteinases MMP-1, MMP-2, and MMP-13 are overexpressed in primary nodular melanoma. J Cutan Pathol. 2020;47(2):139\u201345.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"14694_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mc.23130","volume":"59","author":"Y Wang","year":"2020","unstructured":"Wang Y, Ding X, Liu B, Li M, Chang Y, Shen H, et al. Etv4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally. Mol Carcinog. 2020;59(1):73\u201386.","journal-title":"Mol Carcinog"},{"key":"14694_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/genes13040689","author":"S Hosseini","year":"2022","unstructured":"Hosseini S, Rejali L, Pezeshkian Z, Malekian M, Fatemi N, Peyravian N, et al. Oncogenic role of connective tissue growth factor is associated with canonical TGF-\u03b2 cascade in colorectal cancer. Genes. 2022. https:\/\/doi.org\/10.3390\/genes13040689.","journal-title":"Genes"},{"issue":"1","key":"14694_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-022-06514-6","volume":"193","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Tao Z, Chen Y, Lin S, Zhu M, Ji W, et al. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT. Breast Cancer Res Treat. 2022;193(1):65\u201381.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"14694_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12935-024-03248-x","volume":"24","author":"PJ Chua","year":"2024","unstructured":"Chua PJ, Ow SH, Ng CT, Huang WH, Low JT, Tan PH, et al. Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression. Cancer Cell Int. 2024;24(1):59.","journal-title":"Cancer Cell Int"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14694-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14694-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14694-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:20:34Z","timestamp":1761207634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14694-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14694"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14694-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No additional ethical approval was necessary for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1633"}}